Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)

G9075
HCPCS Code

2023 HCPCS
Billable/Valid Code

G9075 is a valid 2023 HCPCS Code that could be used to indicate Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project) for reimbursement purposes.

G9075 belongs to Medical Care Type of Service and has been in effect since Jan 01, 2007.

Short description for G9075 HCPCS code:

Onc dx brst metastic/ recur

HCPCS G9075

G9075 code information

HCPCS code:	G9075
Description:	ONCOLOGY; DISEASE STATUS; INVASIVE FEMALE BREAST CANCER (DOES NOT INCLUDE DUCTAL CARCINOMA IN SITU); ADENOCARCINOMA AS PREDOMINANT CELL TYPE; M1 AT DIAGNOSIS, METASTATIC, LOCALLY RECURRENT, OR PROGRESSIVE (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)
Effective Date:	Jan 01, 2007
Added Date:	Jan 01, 2006
Termination Date:	HCPCS G9075 was terminated on Nov 30, -0001
Pricing indicator:	`00` - SERVICE NOT SEPARATELY PRICED BY PART B (E.G., SERVICES NOT COVERED, BUNDLED, USED BY PART A ONLY, ETC.) PHYSICIAN FEE SCHEDULE AND NON-PHYSICIAN PRACTITIONERS
Multi Pricing indicator:	`9` - NOT APPLICABLE AS HCPCS NOT PRICED SEPARATELY BY PART B (PRICING INDICATOR IS 00) OR VALUE IS NOT ESTABLISHED (PRICING INDICATOR IS ´99´)
Coverage code:	`C` - CARRIER JUDGMENT
BETOS code:	`P7B` - ONCOLOGY - OTHER
Action code:	`N` - NO MAINTENANCE FOR THIS CODE
Type of Service:	`1` - MEDICAL CARE
Anesthesia BUQ:	0